Professional Documents
Culture Documents
Sanitation of Pharmaceutical Facilities
Sanitation of Pharmaceutical Facilities
ABSTRACT USP <1072> lists common materials used ic notation) or by International Standard
Maintaining environmental control in clean rooms that should be considered ISO14644 (numeric classiication). he
including microbiological contamina- when developing disinfectant surface test- cleanliness of the air is controlled by the
tion in a pharmaceutical manufacturing ing. To demonstrate the efectiveness of a HVAC system (Heating, Ventilation and
environment is primarily dependent on disinfectant, it must be challenged using a Air-Conditioning) in the facility.
the facility sanitization program. Saniti- panel of organisms that is relective of the
zation considerations are speciic for fa- natural microlora of the facility. he bio- Cleanrooms are designed to minimize
cility rooms, equipment, and personnel. cidal activity of the disinfectant should be and to control contamination. here are
Sanitization comprises cleaning and dis- taken into account when selecting the panel many sources of contamination. he at-
infection. Cleaning is necessary prior to of organisms. he use of microbial isolates mosphere contains dust, microorganisms,
the application of disinfectant to enable from the manufacturing facility is increas- condensates, and gases. Manufacturing
suicient contact time of the disinfecting ingly becoming a regulatory expectation. processes will also produce a range of
agent with the surface. Disinfectants vary Surface tests cannot demonstrate the efect contaminants. Wherever there is a pro-
in their spectrum of activity, modes of ac- of a range of environmental factors in ac- cess which grinds, corrodes, fumes, heats,
tion, sites of action in microorganisms, and tual environmental conditions. Field tri- sprays, turns, etc., particles and fumes
eicacy. Disinfectants kill vegetative mi- als are an important part of the qualiica- are emitted and will contaminate the sur-
cro-organisms but do not necessarily kill tion of a sanitizer to determine if cleaning roundings (1). he foremost concern in
bacterial spores. here are many diferent techniques are suitable and if the cleaning pharmaceutical manufacturing of sterile
types and categorizations of disinfectants frequencies of cleanrooms require modii- products is microbial contamination.
such as non-oxidizing disinfectants and cation.
oxydizing agents. Many pharmaceutical Maintaining environmental control in
manufacturers will have two “in-use” disin- INTRODUCTION a pharmaceutical manufacturing environ-
fectants and a third disinfectant for major his article provides an introduction to ment is primarily dependent on the facil-
contamination incidents. Rotation of dis- the sanitization and bio-decontamination ity’s cleaning and disinfection program.
infectants is oten implemented to satisfy of pharmaceutical manufacturing facilities. he program requires the selection of the
the requirements of regulators. Cleaning his topic is especially relevant for manu- appropriate disinfectants, their proper ap-
and disinfection must be detailed in a Stan- facturing of sterile products. plication, and validation of their capability
dard Operating Procedure (SOP) to ensure Pharmaceutical facilities used for manu- to inactivate vegetative cells.
consistency of practice. he efectiveness of facturing of sterile products are comprised
cleanroom sanitization is assessed through of a series of rooms called cleanrooms. TYPES OF SANITIZATION
the site environmental monitoring pro- Cleanrooms and zones are typically classi- Sanitization difers depending on the
gram. Viable monitoring is undertaken us- ied according to their use or main activity speciic area of concern. hree areas are
ing microbiological growth medium. Reg- within each room or zone. Cleanrooms are discussed: Rooms, equipment, and person-
ulatory agencies expect the pharmaceutical conirmed by the cleanliness of the air by nel.
manufacturer to have evaluated the eicacy the measurement of particles. Pharmaceu-
of disinfectants. While suspension testing tical cleanrooms are classiied by standards
is useful for initial screening, comparative in either EU and WHO GMP guidance
surface (or carrier) testing is more relevant. for aseptically illed products (alphabet-
www.ivtnetwork.com
Tim Sandle
www.ivtnetwork.com
Tim Sandle
EU GMP Guide states that “where disinfec- Viable monitoring is designed to detect documented evidence that the disinfectant
tants are used, more than one type should levels of bacteria and fungi present in de- demonstrates bactericidal, fungicidal, and/
be employed” (Annex 1). Nevertheless, the ined locations during a particular stage in or sporicidal activity necessary to control
case for rotation has not been scientiical- the processing and illing of product. Vi- microbial contamination in the facility
ly proven in that there are very few studies able monitoring is designed to detect mi- (15).
providing empirical evidence. However, it cro-organisms and answer questions such
remains that rotation is oten implemented as how many, how frequent, when do they he selection of surfaces to be assessed
to satisfy the requirements of regulators. occur and why do they occur? (14) for disinfectant eicacy is an important
consideration. Given the multitude of
Cleaning and disinfection procedures Viable monitoring is undertaken using available surfaces in a facility, a pragmatic
Cleaning and disinfection must be de- microbiological growth medium (agar or view should be taken. Where the surface
tailed in a Standard Operating Procedure other substances) in diferent presenta- is considered critical in terms of cleaning
(SOP) to ensure consistency of practice. tions. It is important that the culture media and disinfection, i.e., contact with product
Furthermore, suicient detail in SOPs is used for environmental monitoring con- and personnel, it should be considered for
important because detergents and disin- tains a neutralizer to eliminate any residues disinfectant surface testing. USP chap-
fectants are only partially efective if they of the disinfectant. ter <1072> lists common materials used
are not applied correctly. An SOP should in clean rooms that should be considered
describe: he environmental monitoring program when developing disinfectant surface test-
• he type of detergents and disinfec- is normally controlled by the site microbi- ing. Stainless steel and other surfaces
ology department who establish the appro- within the manufacturing facility should
tants to be used. hese agents must be
priate frequencies and durations for moni- be tested such as diferent grades of vinyl
compatible
toring based on a risk assessment approach. and stainless steel, diferent types of plastic,
• he frequency of rotation of disinfec-
he sampling plan takes into account the glass from windows and vessels, and other
tants
cleanliness level required at each site to be materials as appropriate.
• A list of suitable cleaning materials
sampled.
• Cleaning techniques
he test involves examining prepa-
• Contact times
QUALIFICATION OF rations of micro-organisms dried onto
• Rinsing
DISINFECTANTS surfaces. A prepared sample of the disin-
• Frequency of cleaning and disinfection
Regulatory agencies expect the phar- fectant is added to the dried surface con-
• Procedure for the transfer of cleaning maceutical manufacturer to have evaluated taining and microbial suspension. he
agents and disinfectants into and out the eicacy of disinfectants. While suspen- surface is then transferred to a previously
of clean areas sion testing is useful for initial screening, it validated neutralization medium and test-
• Procedure for sterilization of disinfec- is surface (or carrier) testing that is more ing performed to measure the reduction
tants relevant. Qualiication of a disinfectant is in viable counts. One variation of the test
• Holding times for detergents and dis- demonstrated through performance testing involves drying 0.05 ml suspensions of
infectants. to show that the disinfectant is capable of the micro-organisms with interfering sub-
reducing the microbial bioburden found on stances such as bovine serum albumin onto
ASSESSING SANITIZATION manufacturing area surfaces. Representa- diferent surfaces. he micro-organisms
EFFECTIVENESS tive manufacturing surface samples are in- should have a population range of 1.5 - 5.0
he efectiveness of cleanroom saniti- oculated with a selection of microbial chal- x 108 for bacteria and 1.5 - 5.0 x 107 for
zation is assessed through environmental lenge organisms. A disinfectant is applied fungi and are equilibrated to 25oC before
monitoring. Environmental monitoring to the inoculated surfaces and exposed for use. Once applied to the surface, the drying
is a program which examines the numbers a predetermined contact time ater which of the micro-organisms maybe accelerated
and occurrences of viable micro-organ- surviving organisms are recovered using a using an incubator operating at 36-38oC.
isms and non-viable particles such as dust qualiied disinfectant-neutralizing broth Disinfectant solutions (where disinfectants
or skin cells. Environmental monitoring is and test method (surface rinse, contact are made with Water of Standard Hard-
ideally targeted to those areas of the pro- plate, or swab). he number of challenge ness) are added to the surfaces. Ater the
duction process where the risk cannot be organisms recovered from the test samples speciied contact time (ive minutes is the
adequately controlled. Trend analysis of (exposed to a disinfectant) is compared target), the surfaces are transferred to the
environmental monitoring data provides to the number of challenge organisms re- validated neutralization medium and then
an indication if the cleanroom disinfection covered from the corresponding control pour plates are prepared for incubation and
program is moving out-of-control (13). sample (not exposed to a disinfectant) to counting. An alternative method is avail-
Viable monitoring of surfaces is the most determine the ability of the disinfectant to able using a soaked swab step (16).
relevant approach for assessing the efec- reduce the microbial bioburden. Success- To demonstrate the efectiveness of a
tiveness of surface sanitization. ful completion of the validation qualiies disinfectant, it must be challenged using a
the disinfectant evaluated for use. he dis- panel of organisms that is relective of the
infectant eicacy validation should provide natural microlora of the facility. he bio-
www.ivtnetwork.com